Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Trial

Table 4

Changes of quality of life of breast cancer patients with CIPN assessed by the SF-36 from baseline to the end of the final acupuncture session.

Variable	SF-36 score, mean (SD)		F (p-value)
	Baseline	At the end of the last treatment
Physical functioning	70.00; (22.236)	77.50; (17.361)	5.548; (0.043)^∗
Role limitations due to physical health problems	54.38; (22.831)	69.38; (20.927)	11.676; (0.008)^∗
Role limitations due to emotional problems	58.33; (36.430)	71.67; (21.943)	1.595; (0.238)
Vitality; (energy/fatigue)	48.13; (28.573)	51.88; (21.661)	0.503; (0.496)
Emotional well-being; (general mental health)	55.50; (16.406)	64.50; (18.626)	4.734; (0.058)
Social functioning	60.00; (28.747)	82.50; (18.819)	12.356; (0.007)^∗
Bodily pain	47.50; (19.149)	127.25; (228.207)	1.258; (0.291)
General health perceptions	50.00; (26.667)	58.00; (26.479)	16.000; (0.003)^∗

statistically significant (p < 0.05).